FK-506: Profile of an important new immunosuppressant
- 31 July 1990
- journal article
- Published by Elsevier in Transplantation Reviews
- Vol. 4 (1) , 1-13
- https://doi.org/10.1016/s0955-470x(11)80001-7
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- FK-506 enters the clinicImmunology Today, 1990
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- EFFECTS OF COMBINATION TREATMENT WITH FK506 AND CYCLOSPORINE ON SURVIVAL TIME AND VASCULAR CHANGES IN RENAL-ALLOGRAFT-RECIPIENT DOGSTransplantation, 1989
- Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosusClinical Immunology and Immunopathology, 1989
- EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITROTransplantation, 1989
- FK-506 — How much potential?Immunology Today, 1989
- Immunosuppressive effect of FK506 on collagen-induced arthritis in ratsClinical Immunology and Immunopathology, 1988
- PROLONGATION OF SKIN ALLOGRAFT SURVIVAL IN RATS BY A NOVEL IMMUNOSUPPRESSIVE AGENT, FK 506Transplantation, 1988
- STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG-TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATSTransplantation, 1987
- STUDIES OF THE EFFECTS OF FK506 ON RENAL ALLOGRAFTING IN THE BEAGLE DOGTransplantation, 1987